Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$788K | -$2.29M | -$13.0M | -$15.3M | -$19.9M | -$21.1M |
| Net income | -$1.07M | -$4.43M | -$13.0M | -$14.6M | -$19.4M | -$21.0M |
| EPS (diluted) | -$0.29 | -$1.03 | -$1.59 | -$0.72 | -$0.73 | -$0.62 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$600K | -$3.23M | -$9.95M | -$12.1M | -$14.5M | -$14.0M |
| Capital expenditures | — | — | $0.00 | $256K | $201K | $600K |
| Free cash flow | — | — | -$9.95M | -$12.3M | -$14.7M | -$14.6M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.0K | $13.2M | $3.59M | $16.2M | $2.38M | $4.38M |
| Total assets | $51.0K | $14.0M | $4.04M | $17.1M | $3.28M | $5.84M |
| Total liabilities | $4.84M | $588K | $1.67M | $1.19M | $1.62M | $3.24M |
| Shareholders' equity | -$4.79M | $13.4M | $2.37M | $15.9M | $1.65M | $2.60M |
| Retained earnings | -$4.80M | -$9.22M | -$22.2M | -$36.8M | -$56.3M | -$77.3M |
| Shares (wtd avg diluted) | 3.65M | 4.28M | 8.17M | 20.3M | 26.6M | 33.7M |
Every figure is extracted from HeartBeam, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.